Skip to main content

Advertisement

Log in

Antibodies to melanoma cell and BCG antigens in sera from tumour-free individuals and from melanoma patients

  • Letter
  • Published:

From Nature

View current issue Submit your manuscript

Abstract

THE Mycobacterium bovis strain BCG shares antigenic components with several neoplasms, including human malignant melanoma1–5. Other species of bacteria also have antigenic similarities with a guinea pig hepatoma6. Antibodies to mycobacteria and other bacterial antigens are universally present in sera from normal humans7,8. Since there is a broad range of shared or cross-reactive antigens among mycobacteria and unrelated microorganisms9, it is conceivable that an immune response by normal humans to mycobacteria has been induced by exposure to taxonomically unrelated microorganisms ubiquitous in the environment. Cytotoxic reactions by lymphoid cells from normal animals and humans to many kinds of tumour cells have been reported10–15. Antibodies in sera from patients with various neoplasms have often been observed that react with antigens derived from their own tumours or from those of the same histological type16–18.Humoral responses to tumour-associated antigens have also been noted in sera from normal humans, gibbons and mice19–21. We have investigated whether sera from normal, tumour-free humans contain antibodies which can react with melanoma-associated as well as with BCG antigens. If this were the case, perhaps immunological reactions by normal humans to certain tumours are widespread and reflect previous sensitisation by microorganisms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Borsos, T., and Rapp, H. J., J. natn. Cancer Inst., 51, 1085–1086 (1973).

    Article  CAS  Google Scholar 

  2. Bucana, C., and Hanna, M. G., Jr, J. natn. Cancer Inst., 53, 1313–1323 (1974).

    Article  CAS  Google Scholar 

  3. Minden, P., McClatchy, J. K., Wainberg, M., and Weiss, D. W., J. natn. Cancer Inst., 53, 1325–1331 (1974).

    Article  CAS  Google Scholar 

  4. Minden, P., Sharpton, T. R., and McClatchy, J. K., J. Immun., 116, 1407–1414 (1976).

    CAS  PubMed  Google Scholar 

  5. Lewis, M. G., et al., in The Present Status of BCG in Cancer Immunotherapy (edit. by Lamoureux, E. G., Portelance, V., and Turcotte, R.), (Grune and Stratton, New York, 1976).

    Google Scholar 

  6. Minden, P., Sharpton, T. R., and McClatchy, J. K., Cancer Res., 36, 1680–1685 (1976).

    CAS  PubMed  Google Scholar 

  7. Bardana, E. J., McClatchy, J. K., Farr, R. S., and Minden, P., Clin., exp. Immun., 13, 65–77 (1973).

    Google Scholar 

  8. Minden, P., and Farr, R. S., Chest, 68, 749–750 (1975).

    Article  CAS  Google Scholar 

  9. Minden, P., McClatchy, J. K., Cooper, R., Bardana, E. J., and Farr, R. S. Science, 176, 57–58 (1972).

    Article  ADS  CAS  Google Scholar 

  10. Blair, P. B., Lane, M. A., and Yagi, M. J., J. Immun., 112, 693–705 (1974).

    CAS  PubMed  Google Scholar 

  11. Herberman, R. B., Nunn, M. E., Holden, H. T., and Lavrin, D. H., Int. J. Cancer, 16, 216–229 (1975).

    Article  CAS  Google Scholar 

  12. Kiesling, R., Klein, E., and Wigzell, H., Eur. J. Immun., 5, 112–121 (1975).

    Article  Google Scholar 

  13. Tagasugi, M., Mickey, M. R., and Terasaki, P. I., Cancer Res., 33, 2898–2902 (1973).

    Google Scholar 

  14. de Vries, J. E., Meyering, M., van Dongen, A., and Rumke, P., Int. J. Cancer, 15, 391–400 (1975).

    Article  CAS  Google Scholar 

  15. Canevari, S., Fossati, G., and Della Porta, G., J. natn. Cancer Inst., 56, 705–709 (1976).

    Article  CAS  Google Scholar 

  16. Hellström, I., Hellström, K. E., Pierce, G. E., and Yang, J. P. S., Nature, 220, 1352–1354 (1968).

    Article  ADS  Google Scholar 

  17. Lewis, M. G., Med. Clinics of North America, 56, 481–499 (1972).

    Article  CAS  Google Scholar 

  18. Bodurtha, A. J., Chee, D. O., Laucius, J. F., Mastrangelo, M. J., and Prehn, R. T., Cancer Res., 35, 189–193 (1975).

    CAS  PubMed  Google Scholar 

  19. Bias, W. B., Santos, G. W., Burke, P. J., Mullins, G. M., and Humphrey, R. L., Science, 178, 304–306 (1972).

    Article  ADS  CAS  Google Scholar 

  20. Aoki, T., et al., Science, 19, 1180–1183 (1976).

    Article  ADS  Google Scholar 

  21. Hanna, M. G., Jr, Ihle, J. N., Batzing, B. L., Tennant, R. W., and Schenley, C. K., Cancer Res., 35, 164–171 (1975).

    PubMed  Google Scholar 

  22. Minden, P., Farr, R. S., and Trembath, J., Immunochemistry, 12, 477–479 (1975).

    Article  CAS  Google Scholar 

  23. Dixon, F. J., The Harvey Lectures, 58, 21 (Academic, New York, 1963).

    Google Scholar 

  24. Lewis, M. G., Phillips, T. M., Cook, K. B., and Blake, J., Nature, 232, 52–53 (1971).

    Article  ADS  CAS  Google Scholar 

  25. Rowley, D. A., Fitch, F. W., Stuart, F. P., Kohler, H., and Cosenza, H., Science, 181, 1133–1141 (1973).

    Article  ADS  CAS  Google Scholar 

  26. Lewis, M. G., Hartmann, D., and Jerry, L. M., Proc. N. Y. Acad. Sci., (in the press).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

MINDEN, P., JARRETT, C., MCCLATCHY, J. et al. Antibodies to melanoma cell and BCG antigens in sera from tumour-free individuals and from melanoma patients. Nature 263, 774–777 (1976). https://doi.org/10.1038/263774a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/263774a0

  • Springer Nature Limited

This article is cited by

Navigation